论文信息 - Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII - 字舞流文

Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII

M. Friedrich | M. Muenz | B. Rattel | O. Thomas | J. Wahl | J. Bailis | Grit Lorenczewski | F. Lee | A. Sternjak | M. Balazs | Ines Ullrich | Alexander Sternjak